MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Reduced non-REM sleep in Parkinson disease is associated with memory impairment and non-motor symptom burden

    S. Shah, C. Dintino, S. Lageman, N. Mukhopadhyay, E. Shelton, S. Holden, J. Broussard, L. Cloud, M. Barrett, B. Berman (Richmond, USA)

    Objective: To evaluate the relationship between sleep architecture and cognitive function in Parkinson disease (PD). Background: About half of PD patients develop mild cognitive impairment…
  • 2023 International Congress

    cerebellar cognitive affective syndrome is frequent in rfc1-related disorder

    C. Lobo, NB. Santos, F. Lima, T. Rezende, PC. Matos, JL. Pedroso, O. Barsottini, W. Marques Jr, M. França Jr (Campinas, Brazil)

    Objective: To describe the prevalence and clinical profile of cerebellar cognitive affective syndrome (CCAS) in patients with RFC1-related disorder. Background: Since the recent description of…
  • 2023 International Congress

    Description of a series of GAA-FGF14 ataxia / SCA27b patients

    P. Iruzubieta, D. Pellerin, J. Ruiz, A. Bergareche, E. Mondragon, I. Albajar, J. Equiza, G. Nuñez, P. Arratibel, F. Moreno, J. Poza, M. Ruibal, R. Fernández-Torrón, A. Vinagre, I. Croitoru, M. Dicaire, B. Brais, H. Houlden, A. Lopez Munain (San Sebastián, Spain)

    Objective: To describe the main features of a series of 12 patients with GAA-FGF14 ataxia.To describe the main features of a series of 12 patients…
  • 2023 International Congress

    AI-Guided Microelectrode Recording for GPi DBS in Parkinson’s disease

    J. Wong, S. Aghili-Mehrizi, R. Forghani, A. Babajani, M. Okun, C. Butson, R. Fang (Gainesville, USA)

    Objective: To evaluate the feasibility of using a machine learning algorithm to interpret intraoperative microelectrode recording (MER) during deep brain stimulation (DBS) lead placement surgery.…
  • 2023 International Congress

    Hyperkinetic dystonia in dyskinetic cerebral palsy responds to combined DBS stimulation in thalamus and pallidum.

    A. Zakharova, J. Maclean, T. Sanger (Orange, USA)

    Objective: To describe the response of hyperkinetic dystonia in four pediatric patients with dyskinetic CP to combined DBS stimulation in thalamus and pallidum. Background: Dystonia…
  • 2023 International Congress

    Clinal comprehensive Next-gen gene panel for Parkinson’s Disease

    Z. Niu, E. Lauer, S. Roellinger, L. Hasadsri, O. Ross, R. Savica (Rochester, USA)

    Objective: Parkinson's disease (PD) is a neurodegenerative disorder that affects millions of people. There is growing evidence on both gene mutations associated with PD and…
  • 2023 International Congress

    Topical Botulinum-Toxin-like Alternatives: A Systematic Literature Review

    S. Maytharakcheep, O. Phokaewvarangkul, R. Bhidayasiri (bangkok, Thailand)

    Objective: To perform a systematic review exploring the relevant literature on BoNT and BoNT-like substances in topical form and clinical trials focusing on facial muscle…
  • 2023 International Congress

    Falls in Mild Cognitive Impairment with Lewy bodies (MCI-LB).

    E. Lirani Silva, S. Waite, C. Hamilton, P. Donaghy, J. O'Brien, J. Taylor, J. Lloyd, L. Allan, M. Firbank, A. Thomas, A. Yarnall (Newcastle, United Kingdom)

    Objective: to identify clinical, physical activity and mobility measures that differentiate patients with mild cognitive impairment with Lewy bodies (MCI-LB) fallers and non-fallers from cognitively…
  • 2023 International Congress

    Inhibition of LRRK2 kinase activity promotes glucocerebrosidase transport to the lysosomes in primary monocyte-derived macrophages from patients with GBA-associated Parkinson’s disease

    K. Basharova, A. Bezrukova, A. Izyumchenko, G. Baydakova, I. Miliukhina, E. Zakharova, S. Pchelina, T. Usenko (Gatchina, Russian Federation)

    Objective: The aim was to evaluate the effectiveness of leucine-rich repeat kinase 2 (LRRK2) kinase activity inhibition in restoring transport of the enzyme glucocerebrosidase (GCase),…
  • 2023 International Congress

    Identification of potential oxidative biomarkers in saliva of Parkinson’s disease patients

    J. Rungta, A. Roy, S. Choudhury, S. Ansari, P. Chatterjee, R. Khatun, R. Pramanik, S. Dey, H. Kumar (Kolkata, India)

    Objective: The goal of this study is to ascertain whether salivary oxidative markers are altered in Parkinson’s Disease (PD) and if there is an association of these markers with disease…
  • « Previous Page
  • 1
  • …
  • 161
  • 162
  • 163
  • 164
  • 165
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley